BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He S, Lin Q, Qu M, Wang L, Deng L, Xiao L, Zhang Z, Zhang L. Liver-Targeted Co-delivery of Entecavir and Glycyrrhetinic Acid Based on Albumin Nanoparticle To Enhance the Accumulation of Entecavir. Mol Pharm 2018;15:3953-61. [PMID: 30110554 DOI: 10.1021/acs.molpharmaceut.8b00408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li P, Guo X, Liu T, Liu Q, Yang J, Liu G. Evaluation of Hepatoprotective Effects of Piperlongumine Derivative PL 1-3-Loaded Albumin Nanoparticles on Lipopolysaccharide/d-Galactosamine-Induced Acute Liver Injury in Mice. Mol Pharm 2022. [PMID: 35971845 DOI: 10.1021/acs.molpharmaceut.2c00215] [Reference Citation Analysis]
2 Dong H, Hong X, He Y, Bao Z, Zhang Y, Shen S, Wang G, Zhang J, Mo R. A carrier-free metal-organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment. Biomater Sci 2022;10:4356-66. [PMID: 35786722 DOI: 10.1039/d2bm00407k] [Reference Citation Analysis]
3 Mu W, Wang Q, Jia M, Dong S, Li S, Yang J, Liu G. Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice. Int J Mol Sci 2022;23:4903. [PMID: 35563293 DOI: 10.3390/ijms23094903] [Reference Citation Analysis]
4 Kim M, Park SC, Lee DY. Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy. Cancers (Basel) 2021;13:5762. [PMID: 34830916 DOI: 10.3390/cancers13225762] [Reference Citation Analysis]
5 Wu SY, Wang WJ, Dou JH, Gong LK. Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacol Sin 2021;42:18-26. [PMID: 32144337 DOI: 10.1038/s41401-020-0383-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
6 Gong T, Tan T, Zhang P, Li H, Deng C, Huang Y, Gong T, Zhang Z. Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. Biomaterials 2020;258:120296. [PMID: 32781326 DOI: 10.1016/j.biomaterials.2020.120296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li L, Han S, Yang C, Liu L, Zhao S, Wang X, Liu B, Pan H, Liu Y. Glycyrrhetinic acid modified MOFs for the treatment of liver cancer. Nanotechnology 2020;31:325602. [DOI: 10.1088/1361-6528/ab8c03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Hamdi M, Abdel-Bar HM, Elmowafy E, Al-Jamal KT, Awad GAS. An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect. PLoS One 2020;15:e0227231. [PMID: 31923260 DOI: 10.1371/journal.pone.0227231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Lamichhane S, Lee S. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy. Arch Pharm Res 2020;43:118-33. [PMID: 31916145 DOI: 10.1007/s12272-020-01204-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
10 Lin Q, Qu M, Zhou B, Patra HK, Sun Z, Luo Q, Yang W, Wu Y, Zhang Y, Li L, Deng L, Wang L, Gong T, He Q, Zhang L, Sun X, Zhang Z. Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine. J Control Release 2019;311-312:104-16. [PMID: 31484040 DOI: 10.1016/j.jconrel.2019.08.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
11 Li X, Sun R, Liu R. Natural products in licorice for the therapy of liver diseases: Progress and future opportunities. Pharmacol Res 2019;144:210-26. [PMID: 31022523 DOI: 10.1016/j.phrs.2019.04.025] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
12 Jain A, Singh SK, Arya SK, Kundu SC, Kapoor S. Protein Nanoparticles: Promising Platforms for Drug Delivery Applications. ACS Biomater Sci Eng 2018;4:3939-61. [DOI: 10.1021/acsbiomaterials.8b01098] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 15.8] [Reference Citation Analysis]